As of 9:30 AM on the 30th, Celltrion is trading at 348,500 KRW, up 4.34% from the previous day. This marks a 42.54% increase compared to November 2. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net sold 63,113 shares, while foreigners and institutions have net bought 79,340 shares and net sold 31,901 shares, respectively.


On November 25, Celltrion became a market topic with a 23% increase following news about the clinical trial of its COVID-19 antibody treatment.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing